Anti-DENV IgM titers have been shown to be higher in primary compared to secondary infections, with as many as 20% of dengue cases with secondary infection having undetectable levels of anti-DENV IgM in convalescent specimens [16]. The gene discussed is CD40LG; the disease is infection.